Email ID
Password
Scrip   
Novartis building Chinese presence with vaccines acquisition and R&D investment
05 November 2009
Ian Haydock

Novartis has become the latest multinational to set its sights on the fast-growing vaccines market in China, where it has unveiled plans to acquire a Chinese manufacturer, and is also investing $1 billion over the next five years to build up its R&D operations in the country.
The Swiss...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36